Financials
Financial year 2025
BIONUTRICS from Oostende, company number BE0475379578, closed financial year 2025 with a result of € 254,273 after tax. Compared with financial year 2024, the result moved from € 3.3 million to € 254,273. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 7, 2026.
€ 11.5 million
▲ 2% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 254,273
▼ 92% vs 2024
Profit after tax over the fiscal year.
€ 252,791
▼ 28% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 11.3 million.
People and assets in 2025
€ 3,850
▼ € 2.9 million vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 190,830
▲ € 164,854 vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 159 days on average.
€ 179,300
▼ 21% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 16,522,482 | € 16,094,966 | € 11,635,277 | - | |
| Profit after taxes | € 548,965 | € 556,753 | € 3,297,779 | € 254,273 | ▼ 92% |
| Equity | € 7,417,692 | € 7,974,445 | € 11,272,224 | € 11,526,498 | ▲ 2% |
| Total debts | € 1,540,331 | € 1,218,231 | € 259,784 | € 379,170 | ▲ 46% |
| Cash | € 535,370 | € 1,585,593 | € 350,703 | € 252,791 | ▼ 28% |
| Retained profit | € 7,217,692 | € 7,774,445 | € 11,072,224 | € 11,326,498 | ▲ 2% |
| Balance sheet total | € 10,096,040 | € 10,141,261 | € 11,600,009 | € 11,973,667 | ▲ 3% |
| Employees (FTE) | 14.9 | 13.4 | 4.8 | - |
Key figures of BIONUTRICS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to BIONUTRICS?
What happened at BIONUTRICS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Paul Konney stepped down as director. NBB
- Carl Staelens stepped down as director. NBB
- Stijn Oste stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 254,273 (▼ 92% vs 2024). Source: NBB ↗
- Paul Konney became a director. NBB
- Carl Staelens became a director. NBB
- Stijn Oste became a director. NBB
- New establishment in Oostende. KBO
In short
From € 548,965 profit in 2022 to € 254,273 profit in 2025.
Paid € 1.4 million in corporate taxes since 2022.
Best year ever: 2024, with € 3.3 million profit.
Pays suppliers within 159 days on average.
A new publication or filing at BIONUTRICS? We notify you, reason included.
Follow BIONUTRICSDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The shares are held by Metagenics Europe BV (100%).
Directors
According to the 2025 annual accounts
since 2022 · until 2027
Paul Konney
Director
since 2023 · until 2029
since 2023 · until 2029
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Edward Vlietinckstraat 20
8400 Oostende
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0475.379.578
- VAT number
- BE 0475.379.578
- Registered office
- Edward Vlietinckstraat 20, 8400 Oostende
- Names & denominations
- BIONUTRICS
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 24 August 2001
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Overige detailhandel in voedingsmiddelen, neg
Overige detailhandel in voedingsmiddelen in gespecialiseerde winkels, n.e.g.